Cytecom
Coventry, GB · 1 known investors
Find your way into Cytecom
Sign up to see every warm intro you have to Cytecom
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytecom team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation. The technology is aimed at addressing antimicrobial resistance through faster antibiotic susceptibility testing.
Founders & leadership


Investors · 1
How we know: Oxford Technology Management's portfolio page · the Companies House PSC register · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- CYTECOM LTD
- Company number
- 11263781
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 20 Mar 2018
- Registered office
- The Venture Centre University Of Warwick Science Park, Sir William Lyons Road, Coventry, CV4 7EZ
- Nature of business (SIC)
- 26511 — Manufacture of electronic measuring, testing etc. equipment, not for industrial process control72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 19 Mar 2026 · next due 2 Apr 2027
Current officers · 2
- Magdalena Maria Karlikowska — director, appointed 7 Jan 2023
- James Peter Stratford — director, appointed 20 Mar 2018
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Cytecom do?
- Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation. The technology is aimed at addressing antimicrobial resistance through faster antibiotic susceptibility testing.
- Who founded Cytecom?
- Cytecom was founded by Dr. James Stratford, Dr. Munehiro Asally.
- Who are Cytecom's investors?
- Cytecom's investors include Oxford Technology Management.
- Where is Cytecom headquartered?
- Cytecom is headquartered in Coventry, GB.
